Bariatric surgery is an especially cost-effective therapy for managing Type 2 diabetes in moderately and severely obese patients. These findings and others were presented today at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes, hosted by NewYork-Presbyterian Hospital and Weill Cornell Medical College. Cost effectiveness is central to the larger issue of access to surgical treatment of diabetes, says Dr. Francesco Rubino, director of the Congress and director of gastrointestinal metabolic surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Over time, diabetes can wreak havoc on the body’s eyes, cardiovascular system, kidneys, and nerves. A major study by Joslin Diabetes Center researchers, however, has found that some people who have survived diabetes for many decades exhibit remarkably few complications – a discovery that points toward the presence of protective factors that guard against the disease’s effects.
Researchers at Mount Sinai School of Medicine have found that patients with Alzheimer’s disease have lower glucose utilization in the brain than those with normal cognitive function, and that those decreased levels may be detectable approximately 20 years prior to the first symptoms of Alzheimer’s disease. This new finding could lead to the development of novel therapies to prevent the eventual onset of Alzheimer’s. The study is published online in the journal Translational Neuroscience.
Any possible pain relief that marijuana has for people with multiple sclerosis (MS) may be outweighed by the drug’s apparent negative effect on thinking skills, according to research published in the March 29, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.
During a large-scale study of the socioeconomic costs of this neurodegenerative disease, Danish researchers, some from the University of Copenhagen, discovered that very early symptoms of Parkinson’s disease may be revealed in dream or REM sleep. The results were published in the Journal of Neurology, February 2011.
The human brain loses 5 to 10% of its weight between the ages of 20 and 90 years old. While some cells are lost, the brain is equipped with two compensatory mechanisms: plasticity and redundancy. Based on the results of a recent clinical study published in the online version of Brain, A Journal of Neurology, has found that for elderly subjects at risk of developing Alzheimer’s disease, hope may lie in brain plasticity.
Scientists today reported the first strong evidence implicating nicotine as the main culprit responsible for persistently elevated blood sugar levels — and the resulting increased risk of serious health complications — in people who have diabetes and smoke. In a presentation at the 241st National Meeting & Exposition of the American Chemical Society (ACS), they said the discovery also may have implications for people with diabetes who are using nicotine-replacement therapy for extended periods in an attempt to stop smoking.
Mayo Clinic researchers found that dopamine agonists used in treating Parkinson’s disease result in impulse control disorders in as many as 22 percent of patients. Mayo Clinic first reported on this topic in 2005. The follow-up study was published online in the February 2011 issue of Parkinsonism and Related Disorders. Included in this report is a video summary of the study results by the lead researcher.